Hybrid was selected by Abbott Laboratories and their agency Harrison & Star to create artwork for part of an in-depth focus on the innovation of HUMIRA<sup>®</sup> (the first fully human monoclonal antibody approved for rheumatoid arthritis) and its advancements being made in the dermatology community.
The challenge here:
Using one main key visual, portray two key potential treatments for HUMIRA® indications – early RA, and psoriatic arthritis – and feature the monoclonal antibody in the artwork.
Hybrid developed the last MOA animation (appx. 4 minutes) and has been selected
